Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Frazier

Showing results (411-420 of 418) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 418 results.
Oncotarget|December 13, 2012
Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-AmericansKyle M Walsh, Christopher I Amos, Angela S Wenzlaff, et al.
The Journal of Physiology|May 11, 2025
A polygenetic rat model of divergent aerobic capacity reveals a liver-brain interaction impacting Alzheimer's disease-like phenotypesColton R Lysaker, Benjamin A Kugler, Vivien Csikos, et al.
Cancer Research|September 3, 2004
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumorsLei L Chen, Jonathan C Trent, Elsie F Wu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 11, 2012
Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-AmericansKyle M Walsh, Ivan P Gorlov, Helen M Hansen, et al.
British Journal of Cancer|August 30, 2008
Phase II trial of imatinib mesylate in patients with metastatic melanomaK B Kim, O Eton, D W Davis, et al.
Plos Medicine|June 19, 2009
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancerSteven T Lott, Nanyue Chen, Dawn S Chandler, et al.
The Lancet. Oncology|September 5, 2020
Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage GuidelinesSumit Gupta, Joanne Aitken, Ute Bartels, et al.
Cancer Immunology, Immunotherapy : CII|December 27, 2011
Exploiting antitumor immunity to overcome relapse and improve remission durationLei L Chen, Xinjian Chen, Haesun Choi, et al.
Pageof 42

Showing results (411-420 of 418) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 418 results.
Oncotarget|December 13, 2012
Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-AmericansKyle M Walsh, Christopher I Amos, Angela S Wenzlaff, et al.
The Journal of Physiology|May 11, 2025
A polygenetic rat model of divergent aerobic capacity reveals a liver-brain interaction impacting Alzheimer's disease-like phenotypesColton R Lysaker, Benjamin A Kugler, Vivien Csikos, et al.
Cancer Research|September 3, 2004
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumorsLei L Chen, Jonathan C Trent, Elsie F Wu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 11, 2012
Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-AmericansKyle M Walsh, Ivan P Gorlov, Helen M Hansen, et al.
British Journal of Cancer|August 30, 2008
Phase II trial of imatinib mesylate in patients with metastatic melanomaK B Kim, O Eton, D W Davis, et al.
Plos Medicine|June 19, 2009
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancerSteven T Lott, Nanyue Chen, Dawn S Chandler, et al.
The Lancet. Oncology|September 5, 2020
Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage GuidelinesSumit Gupta, Joanne Aitken, Ute Bartels, et al.
Cancer Immunology, Immunotherapy : CII|December 27, 2011
Exploiting antitumor immunity to overcome relapse and improve remission durationLei L Chen, Xinjian Chen, Haesun Choi, et al.
Pageof 42